Rodacki Melanie, Krakauer Marcio, Franco Denise Reis, Dualib Patricia Medici, Sancovski Mauro, Zajdenverg Lenita
Internal Medicine Department, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
Diabetes League, ABC Medical School, Santo André, SP, Brazil.
Diabetol Metab Syndr. 2025 Aug 9;17(1):322. doi: 10.1186/s13098-025-01854-x.
Diabetes in pregnancy increases maternal and fetal risks as well as the burden of chronic complications and comorbidities associated with this condition. In addition to HbA1c and blood glucose monitoring (BGM), continuous glucose monitoring systems (CGM) provide a complementary tool that enables comprehensive glycemic assessments and improves glycemic control. This review highlights the clinical value of CGM in the management of diabetes in pregnancy, encompassing type 1 diabetes, type 2 diabetes, gestational diabetes mellitus (GDM), but also early GDM. CGM derived metrics, such as time in range (TIR) and mean glucose levels, are associated with adverse pregnancy outcomes, emphasizing the importance of optimizing glycemic control. Overall, CGM is a valuable tool for detecting glucose fluctuations in pregnancies complicated by all forms of diabetes.
妊娠期糖尿病会增加母婴风险，以及与此病症相关的慢性并发症和合并症负担。除糖化血红蛋白（HbA1c）和血糖监测（BGM）外，持续葡萄糖监测系统（CGM）提供了一种补充工具，可实现全面的血糖评估并改善血糖控制。本综述强调了CGM在妊娠期糖尿病管理中的临床价值，包括1型糖尿病、2型糖尿病、妊娠期糖尿病（GDM），还有早期GDM。CGM得出的指标，如血糖达标时间（TIR）和平均血糖水平，与不良妊娠结局相关，强调了优化血糖控制的重要性。总体而言，CGM是检测各种形式糖尿病合并妊娠中血糖波动的宝贵工具。
